Veradermics, Incorporated (MANE)

Veradermics Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2024	Dec 31, 2023
Selling, General & Admin	-	0	0
Research & Development	-	0.02	0.01
Operating Expenses	-	0.03	0.02
Operating Income	-0.06	-0.03	-0.02
Interest Expense (Income)	-0	0	-0
Other Expense (Income)	-0	-0	-
Pretax Income	-0.06	-0.03	-0.02
Net Income	-0.05	-0.03	-0.02
Net Income Common	-0.06	-0.03	-0.02
Free Cash Flow	-0.05	-0.02	-0.01
EBITDA	-0.05	-0.03	-0.02
EBIT	-0.05	-0.03	-0.02

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).